Viral CD30 for treating inflammatory disease
A viral CD30 polypeptide that may be used to treat inflammatory diseases for example autoimmune diseases, rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis. Viral CD30 works in the same way as human CD30 antibodies to neutralise interactions between CD30 ligand and its receptor but may have additional effects to CD30 antibodies by inducing signalling in cells expressing CD30 ligand.
